← Evidence map

ArticleCephalalgia : an international journal of headache2022

Atogepant - an orally-administered CGRP antagonist - attenuates activation of meningeal nociceptors by CSD.

Andrew M Strassman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 35332801